Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check9 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference4%
- Check16 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.3%
- Check52 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.3%
- Check73 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.